Euro NCAP to Launch New 2025 Car Safety Results
WhatLatest Euro NCAP results published online and via social media.WhenWednesday 15 October…
Silynxcom Receives $935,000 Order from Elite Tactical Unit for Advanced In-Ear Solutions Enhancing Operator Safety in High-Risk Operations
October 08, 2025 09:05 ET | Source: Silynxcom Ltd. Netanya, Israel, Oct.…
Abivax Announces Late-Breaking Presentation of 8-Week ABTECT Trial Results with Updated Safety Data
Abivax Announces Late-Breaking Presentation of 8-Week ABTECT Trial Results with Updated Safety…
Volvo Trucks: Advancing Road Safety Across Southeast Asia
Collaboration with Schools and Communities to Protect Children and Vulnerable Road Users…
New Long-term Safety Data from the Completed Phase 3 SOLARIS Trial Support the Potential of Olanzapine LAI (TEV-‘749) as the First Long-Acting Olanzapine Treatment Option for Schizophrenia with No PDSS Observed
Through Week 56 in the SOLARIS trial, there were no suspected or…
Japan Ground Self-Defense Force Adopts MEDIROM MOTHER Labs REMONY for Advanced Health Monitoring and Heatstroke Safety
TOKYO, Sept. 18, 2025 (GLOBE NEWSWIRE) -- MEDIROM Healthcare Technologies Inc. (NASDAQ:…
Global Safety Ratings Reach Record High
73% of adults feel safe walking alone at night; wide gender and…
Monopar to Present New Long-Term Neurological Efficacy and Safety Data for ALXN1840 in Wilson Disease at the 150th American Neurological Association Annual Meeting
WILMETTE, Ill., Sept. 14, 2025 (GLOBE NEWSWIRE) -- Monopar Therapeutics Inc. (“Monopar”…
New names set high standards for safety: Togg and firefly shake up the EV market
LEUVEN, BELGIUM – The chances are you won’t have heard of it…
Mineralys Therapeutics Presents Subgroup Analyses of Phase 3 Launch-HTN Trial Demonstrating Efficacy and Safety of Lorundrostat in Hypertension Participants with High Unmet Medical Need
~Pivotal Launch-HTN trial of novel aldosterone synthase inhibitor lorundrostat enrolled a diverse…
